Combination Therapy In Dyslipidemia - Image 1

£72.86

Adis Combination Therapy In Dyslipidemia

Name: Combination Therapy In Dyslipidemia
Brand: Adis
Price: 72.86 GBP
Availability: InStock

Cardiovascular

This is the most expensive it has ever been. Walk away.

£73 today · previous high £73 · all-time low £73

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 35 days • 35 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 35 days • 1 price levels

Days at Price

Price Analysis

Most common price: £73 (35 days, 100.0%)

Price range: £73 - £73

Price levels: 1 different prices over 35 days

Description

Comprising contributions from leading lipidologists from around the world, this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia and includes discussion of future therapies that are currently in late stages of clinical evaluation. Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve adequate control of their serum lipid levels with monotherapy. However, recent US and European guideline recommendations, based on randomized, controlled trials, fail to discuss combination therapy options for patients with dyslipidemia. Statins remain the mainstay of drug therapy for hyperlipidemia and chapters in this book specifically examine the role of add-on therapy with different agents modulating the different lipid fractions in the blood, e.g. bile acid sequestrants, fibric acid derivatives (fibrates), omega-3 fatty acids (fish oils), inhibitors of Niemann-Pick C1 like 1 (NPC1L1) protein, cholesteryl ester transfer protein (CETP), apolipoprotein B-100 and microsomal triglyceride transfer protein (MTP) and the emerging proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. There is additional discussion of the role of non-drug therapy options such as nutraceuticals, functional foods and lipoprotein apheresis. The book also discusses the combination of antihypertensive drugs with lipid-lowering drugs in the management of cardiovascular risk in patents with dyslipidemia.

Product Specifications

Brand: Adis
Format: hardcover
ASIN: 3319204327
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Cardiovascular
Domain: Amazon UK
Release Date: 10 July 2015
Listed Since: 14 May 2015

Barcode

No barcode data available

Adis Combination Therapy In Dyslipidemia

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Humana Dyslipidemias: Pathophysiology, Evaluation and Management

Handbook of Lipidology

Therapeutic Lipidology (Contemporary Cardiology)

Dyslipidemias: Pathophysiology, Evaluation and Management (Contemporary Endocrinology)

Springer Pediatric Dyslipidemia: A Practical Guide - Medical Book

Dyslipidemia Essentials

Therapeutic Lipidology (Contemporary Cardiology)

Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

Lipidology, An Issue of Cardiology Clinics (Volume 36-2) (The Clinics: Internal Medicine, Volume 36-2)

Cholesterol in Atherosclerosis & Coronary Heart Disease

Clinical Lipidology: A Companion to Braunwald's Heart Disease

Lipid Metabolism and Health

Metallocorroles for Attenuation of Atherosclerosis: 120 (Springer Theses)

Risikofaktor Hyperlipidämie

Cholesterol, Lipoproteins, and Cardiovascular Health: Separating the Good (HDL), the Bad (LDL), and the Remnant

Resolving The Cholesterol Controversy: The Scientists Who Proved The Lipid Hypothesis Of Causation Of Atherosclerosis And Coronary Heart Disease

The Cholesterol Wars: The Skeptics vs the Preponderance of Evidence

Lipids: Update on Diagnosis and Management of Dyslipidemia, An Issue of Endocrinology and Metabolism Clinics of North America: Volume 51-3 (The Clinics: Internal Medicine, Volume 51-3)

ApoB in Clinical Care

A Statin-Free Life: A revolutionary life plan for tackling heart disease – without the use of statins

Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis: 180 (Developments in Cardiovascular Medicine, 180)

Lipid-Lowering Therapy and Progression of Coronary Atherosclerosis: 180 (Developments in Cardiovascular Medicine, 180)

Triglycerides and Cholesterol Research